SCHEMBL17028602

SCHEMBL17028602

O=C(O)CCCc1ccc(OCc2cc(F)ccc2-c2ccc([C@H]3CC3(F)F)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 20/20 1.00
FFAR1 O14842 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17028571 1.00 FFAR4 (1.00) FFAR4FFAR1
SCHEMBL17028651 0.90 FFAR4 (0.82) FFAR4FFAR1
SCHEMBL17028595 0.88 FFAR4 (1.00) FFAR4FFAR1
SCHEMBL17028567 0.85 FFAR4 (1.00) FFAR4FFAR1
SCHEMBL15277546 0.84 FFAR4 (0.87) FFAR4FFAR1
SCHEMBL15265176 0.83 FFAR4 (0.75) FFAR4FFAR1
SCHEMBL15265285 0.83 FFAR4 (0.88) FFAR4FFAR1
SCHEMBL17028539 0.82 FFAR4 (1.00) FFAR4FFAR1
SCHEMBL17028578 0.81 FFAR4 (1.00) FFAR4
SCHEMBL15266452 0.81 FFAR4 (0.72) FFAR4FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3107901-A1 COMPOUNDS FOR USE AS GPR120 AGONISTS Piramal Enterprises Limited (IN) 2016-12-28 EP claimed
WO-2015125085-A1 COMPOUNDS FOR USE AS GPR120 AGONISTS Piramal Enterprises Limited (IN) 2015-08-27 WO claimed
EP-3107901-A1 COMPOUNDS FOR USE AS GPR120 AGONISTS Piramal Enterprises Limited (IN) 2016-12-28 EP disclosed
WO-2015125085-A1 COMPOUNDS FOR USE AS GPR120 AGONISTS Piramal Enterprises Limited (IN) 2015-08-27 WO disclosed